Novation and Nucletron sign Three Year Equipment Supply Agreement for Cancer Treatment Systems

October 14 2002  

Columbia, MD September 2002.  Nucletron announces a three-year buying agreement with Novation, the supply company for VHA Inc. and University HealthSystem Consortium (UHC), two national hospital alliances. The agreement, which runs from May 2002 through 2005, focuses on the world-class microSelectron High Dose Rate Brachytherapy Remote Afterloader.


“We are extremely excited about the agreement with Novation.  This partnership will provide VHA, UHC, and HPPI members with contract pricing and high quality buying opportunities,” said Jack Coats, president of Nucletron.  “This relationship will provide greater value to the health care organizations Novation serves and will provide access to state-of-the-art clinical solutions unique to Nucletron.” Mr. Coats stated.  Nucletron is the world leader in high dose rate brachytherapy, having an excellent reputation with the clinicians in the radiotherapy community.


“High quality care and patient safety are priorities for the hospital members we serve,” says Larry McComber, Novation Vice President.  “Our contracting process considers both quality and financial criteria and involves significant member input.  Product offerings with both high quality and competitive pricing, such as this, are valued by the hospitals.”


The microSelectron-HDR Remote Afterloading System provides quality, safety, and reliability to meet the demands of physicians, physicists, and regulatory agencies.  The microSelectron-HDR can be used for the treatment of cancer, whether curative or palliative, at virtually any body site, often on an outpatient basis.


About Novation

Based in Irving, Texas, Novation was established in January 1998 through a combination of the supply programs of VHA Inc. and University Health System Consortium (UHC), two national health care alliances.  Novation serves the purchasing needs of more than 2,300 members and affiliates of VHA and UHC.  Novation also serves more than 5,400 members and clients of HealthCare Purchasing Partners International (HPPI), another group purchasing organization owned by VHA and UHC.  The largest supply chain management company in health care, Novation, manages more than $19 billion in annual purchases for VHA, UHC and HPPI members.  For more information, go to http://www.novationco.com/.
 

• VHA based in Irving, TX is a nationwide network of more than 2,200 leading community-owned health care organizations and their physicians.  It comprises 26% of the nation's community hospitals.  For more information, contact http://www.vha.com/.
• UHC, based in Oak Brook, IL. represents 76% of the academic medical centers in the United States.  It is an alliance of 87 academic medical centers and 113 associate members.  For more information, contact http://www.uhc.edu/.
• HPPI, based in Irving, TX is a group purchasing organization that manages more than $1 billon in annual purchases and markets its services to organizations that do not belong to VHA or UHC.  For more information, contact http://www.hppigpo.com/.

About Nucletron
Nucletron B.V., Veenendaal, The Netherlands, is a worldwide leader in radiotherapy systems and thoracic imaging equipment for radiology and mass chest screening and specializes in some of the world’s most innovative products used for cancer treatment. The company has 11 offices worldwide, including its corporate headquarters in The Netherlands. Nucletron has been a leader in remote afterloading brachytherapy for over 25 years. Nucletron B.V. is a subsidiary of Delft Instruments N.V., an international group of companies with over 900 employees and annual sales of some EUR 180 million. Delft Instruments is listed on the Euronext stock exchange in Amsterdam.